EDIT Next Earnings Date Notes

— Editas Medicine (EDIT) is a leading genome editing company focused on developing transformative therapies using CRISPR technology to treat a broad range of serious genetic diseases. The company’s pipeline primarily includes EDIT-301, a potentially best-in-class treatment for sickle cell disease & beta-thalassemia currently in clinical trials. As you prepare for the next earnings call, jot down that the most relevant business metrics for Editas include clinical trial progress (notably patient enrollment, milestone achievements, & any pivotal efficacy/safety updates), research and development (R&D) expenses, cash burn rate, and overall cash & cash equivalents. Listening for details on partnership revenues or collaborations is also key, as strategic alliances can provide both validation & funding. Importantly, since Editas does not yet have commercialized products, pipeline advancements & the company's ability to efficiently manage its cash runway until commercialization or significant partnership deals will be central to understanding EDIT's long-term trajectory and success. The next projected earnings date for EDIT is 5/11/2026 after close (stay tuned for a confirmed earnings date once announced).

EDIT Next Earnings Date FAQ

On this page we presented the EDIT Next Earnings Date information for Editas Medicine along with recent past earnings dates. For Q4 of 2025, EDIT reported earnings of -0.060/share, with the earnings report taking place on 3/9/2026. For Q3 of 2025, EDIT reported earnings of -0.280/share, with the earnings report taking place on 11/10/2025. For Q2 of 2025, EDIT reported earnings of -0.630/share, with the earnings report taking place on 8/12/2025. For Q1 of 2025, EDIT reported earnings of -0.430/share, with the earnings report taking place on 5/12/2025. For Q4 of 2024, EDIT reported earnings of -0.400/share, with the earnings report taking place on 3/5/2025. Based on these past earnings dates, the projected next earnings date for EDIT is 5/11/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Editas Medicine. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Editas Medicine shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Editas Medicine next earnings dates as well as any other stock out there in our coverage universe, to see when the next EDIT earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up EDIT's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the EDIT next earnings date.